EFTUD2 and hearing loss disorder: ES, which was performed at the age of 8 weeks, and following variant prioritization based on the phenotypic features of hearing loss, dysmorphology, and developmental delay, revealed a splice donor site variant of EFTUD2 (c.271+1G>A).